ArticleBiomolecules & biomedicine2026

Breast cancer response to neoadjuvant chemotherapy: Pre-treatment NLR, PLR, LMR, and SII do not predict pathological complete response or residual cancer burden.

İsmail Zihni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.